Use of spirometry in the diagnosis of COPD: a qualitative study in primary care.
Joo MJ, et al. COPD. 2013;10(4):444-449.
Employment and activity limitations among adults with chronic obstructive pulmonary disease—United States, 2013
Wheaton AG, et al. MMWR Morb Mortal Wkly Rep. 2015;64(11):289-295.
Antibiotics for exacerbations of chronic obstructive pulmonary disease.
Vollenweider DJ, et al. Cochrane Database Syst Rev. 2012;12:CD010257.
Nebulized arformoterol: what is its place in the management of COPD?
Miles MC, et al. Ther Adv Respir Dis. 2013;7(2):81-86.
Comparison of dry powder versus nebulized beta-agonist in patients with COPD who have suboptimal peak inspiratory flow rate.
Mahler DA, et al. J Aerosol Med Pulm Drug Deliv. 2014;27(2):103-109.
Inhaler device selection: special considerations in elderly patients with chronic obstructive pulmonary disease.
Barrons R, et al. Am J Health Syst Pharm. 2011;68(13):1221-1232.
Hospital readmissions following initiation of nebulized arformoterol tartrate or nebulized short-acting beta-agonists among inpatients treated for COPD.
Bollu V, et al. Int J Chron Obstruct Pulmon Dis. 2013;8:631-639.
Factors affecting chronic obstructive pulmonary disease early rehospitalization.
Nantsupawat T, et al. Chron Respir Dis. 2012;9(2):93-98.
Assessment of the factors affecting the failure to use inhaler devices before and after training.
Aydemir Y. Respir Med. 2015;109(4):451-458.
Nonadherence in chronic obstructive pulmonary disease patients: what do we know and what should we do next?
Bender, BG. Curr Opin Pulm Med. 2014;20(2):132-137.
Available for download with iBooks on your Mac or iOS device:
Click Here for Download
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease.
Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2015.
Introducing the COPD Foundation Guide for Diagnosis and Management of COPD, Recommendations of the COPD Foundation.
Rennard S, et al. COPD. 2013;10(3):378-389.
American Lung Association
The American Lung Association is the leading organization working to save lives by improving lung health and preventing lung disease through education, advocacy, and research..
The COPD Foundation’s mission is to prevent and cure Chronic Obstructive Pulmonary Disease and to improve the lives of all people affected by COPD.
American College of CHEST Physicians (CHEST Foundation)
The mission of CHEST Foundation is to develop resources to champion the prevention, diagnosis, and treatment of chest diseases through education, communication, and research.
The Global Initiative for Chronic Obstructive Lung Disease (GOLD)
GOLD partners with health care professionals and public health officials to raise awareness of Chronic Obstructive Pulmonary Disease (COPD) and to improve prevention and treatment of this lung disease for patients around the world.